Cargando…
Fusobacterium nucleatum and cancer
Accumulating evidence demonstrates that the oral pathobiont Fusobacterium nucleatum is involved in the progression of an increasing number of tumors types. Thus far, the mechanisms underlying tumor exacerbation by F. nucleatum include the enhancement of proliferation, establishment of a tumor‐promot...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315032/ https://www.ncbi.nlm.nih.gov/pubmed/35244982 http://dx.doi.org/10.1111/prd.12426 |
_version_ | 1784754462412242944 |
---|---|
author | Alon‐Maimon, Tamar Mandelboim, Ofer Bachrach, Gilad |
author_facet | Alon‐Maimon, Tamar Mandelboim, Ofer Bachrach, Gilad |
author_sort | Alon‐Maimon, Tamar |
collection | PubMed |
description | Accumulating evidence demonstrates that the oral pathobiont Fusobacterium nucleatum is involved in the progression of an increasing number of tumors types. Thus far, the mechanisms underlying tumor exacerbation by F. nucleatum include the enhancement of proliferation, establishment of a tumor‐promoting immune environment, induction of chemoresistance, and the activation of immune checkpoints. This review focuses on the mechanisms that mediate tumor‐specific colonization by fusobacteria. Elucidating the mechanisms mediating fusobacterial tumor tropism and promotion might provide new insights for the development of novel approaches for tumor detection and treatment. |
format | Online Article Text |
id | pubmed-9315032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93150322022-07-30 Fusobacterium nucleatum and cancer Alon‐Maimon, Tamar Mandelboim, Ofer Bachrach, Gilad Periodontol 2000 Review Articles Accumulating evidence demonstrates that the oral pathobiont Fusobacterium nucleatum is involved in the progression of an increasing number of tumors types. Thus far, the mechanisms underlying tumor exacerbation by F. nucleatum include the enhancement of proliferation, establishment of a tumor‐promoting immune environment, induction of chemoresistance, and the activation of immune checkpoints. This review focuses on the mechanisms that mediate tumor‐specific colonization by fusobacteria. Elucidating the mechanisms mediating fusobacterial tumor tropism and promotion might provide new insights for the development of novel approaches for tumor detection and treatment. John Wiley and Sons Inc. 2022-03-04 2022-06 /pmc/articles/PMC9315032/ /pubmed/35244982 http://dx.doi.org/10.1111/prd.12426 Text en © 2022 The Authors. Periodontology 2000 published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Articles Alon‐Maimon, Tamar Mandelboim, Ofer Bachrach, Gilad Fusobacterium nucleatum and cancer |
title |
Fusobacterium nucleatum and cancer |
title_full |
Fusobacterium nucleatum and cancer |
title_fullStr |
Fusobacterium nucleatum and cancer |
title_full_unstemmed |
Fusobacterium nucleatum and cancer |
title_short |
Fusobacterium nucleatum and cancer |
title_sort | fusobacterium nucleatum and cancer |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315032/ https://www.ncbi.nlm.nih.gov/pubmed/35244982 http://dx.doi.org/10.1111/prd.12426 |
work_keys_str_mv | AT alonmaimontamar fusobacteriumnucleatumandcancer AT mandelboimofer fusobacteriumnucleatumandcancer AT bachrachgilad fusobacteriumnucleatumandcancer |